Ibuprofen Arginine and Neural Mobilization Versus Ibuprofen Arginine in the Treatment of Carpal Tunnel Syndrome

Launched by UNIVERSIDAD EUROPEA DE MADRID · Jan 12, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at two different ways to treat carpal tunnel syndrome, a condition that causes pain and discomfort in the hand and wrist. Researchers want to see if combining a special physiotherapy technique with ibuprofen arginine (a type of pain reliever) is more effective than just using ibuprofen arginine alone. The goal is to find out which treatment helps reduce pain better for people with this condition.

To participate in the study, you need to be diagnosed with carpal tunnel syndrome in one hand and understand Spanish well. You should also be able to give your consent to join the trial. Unfortunately, if you have certain medical conditions, like cognitive impairment or recent surgery on the affected arm, you won’t be eligible. If you join, you can expect to receive either the combination treatment or the ibuprofen treatment while being monitored by the research team. This study is currently recruiting participants, so if you or someone you know fits the criteria, it might be a good opportunity to help improve treatment options for carpal tunnel syndrome.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participants must be medically diagnosed with unilateral carpal tunnel syndrome (with confirmative electrodiagnostic findings).
• • Full understanding of written and spoken Spanish (language).
• • Participants must freely consent to participate.
• • The presence of positive Phalen an Tinel sings.
• • The presence of carpal tunnel syndrome signs and symptoms
• Exclusion Criteria:
• • The lack to meet inclusion criterions, the presence of cognitive impairment, tumors, cancer, recent (affected) upper limb surgery or trauma, pregnancy, kinesiophobia, deformities of the (affected) upper limb, recent skin injuries or infections (in the affected upper limb), autoimmune inflammatory conditions or flu type symptoms, allergy to gabapentin, allergy to ibuprofen arginine, and also: participants must not be (during the present investigation) under any type of pain reducing treatment (conservative, homeopathic, invasive or not invasive)